Cart
sales@molnova.com
Elsibucol
CAS No. 216167-95-2
Elsibucol( —— )
Catalog No. M34585 CAS No. 216167-95-2
Elsibucol (AGI 1096) is a VCAM1 inhibitor for the study of organ transplant rejection.Elsibucol is a metabolically stable propanol derivative with antioxidant, anti-inflammatory and anti-proliferative properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 333 | In Stock |
|
| 10MG | 504 | In Stock |
|
| 25MG | 816 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2967 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElsibucol
-
NoteResearch use only, not for human use.
-
Brief DescriptionElsibucol (AGI 1096) is a VCAM1 inhibitor for the study of organ transplant rejection.Elsibucol is a metabolically stable propanol derivative with antioxidant, anti-inflammatory and anti-proliferative properties.
-
DescriptionElsibucol (AGI 1096) is a VCAM1 inhibitor for the study of organ transplant rejection.Elsibucol is a metabolically stable propanol derivative with antioxidant, anti-inflammatory and anti-proliferative properties. It lowers blood cholesterol levels and reduces oxidative stress and inflammatory responses in injured arteries, thereby inhibiting atherosclerosis and protecting endothelial healing after arterial injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216167-95-2
-
Formula Weight602.93
-
Molecular FormulaC35H54O4S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(CCCC(O)=O)C1=C(C(C)(C)C)C=C(SC(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)(C)C)C=C1C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Neonuezhenide
Neonuezhenide is a phenolic compound isolated from Ligustrum officinale, which has strong antioxidant effects on free radical-induced hemolysis of red blood cells.
-
BMY-21502
BMY-21502 is a potential cognitive enhancer that shows anti-hypoxia effects in the KCN-hypoxia model, delays the decay of hippocampal synaptic enhancement in vitro, and can be used to study Alzheimer's disease.
-
Methyl-β-cyclodextri...
Methyl-β-cyclodextrin, a cyclic heptasaccharide, is an effective agent for the depletion of cholesterol from cells; also inhibits PEL cell growth with an IC50 of 3.33-4.23 mM.
